Private Capital Management (Florida)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-35,500
Closed -$905K 191
2025
Q3
$905K Hold
35,500
0.08% 99
2025
Q2
$861K Hold
35,500
0.08% 100
2025
Q1
$900K Hold
35,500
0.1% 82
2024
Q4
$942K Hold
35,500
0.1% 72
2024
Q3
$1.03M Hold
35,500
0.11% 70
2024
Q2
$993K Hold
35,500
0.12% 63
2024
Q1
$985K Hold
35,500
0.11% 62
2023
Q4
$1.02M Buy
35,500
+3,000
+9% +$90.7K 0.11% 68
2023
Q3
$1.08M Buy
+32,500
New +$1.15M 0.13% 61
2020
Q3
Sell
-23,188
Closed -$719K 102
2020
Q2
$719K Buy
+23,188
New +$788K 0.18% 46

Other funds holding PFE

Private Capital Management (Florida)'s PFE Position: Q2 2026 in Review

Private Capital Management (Florida) increased its Pfizer (PFE) stake by 19% in Q2 2026, buying an estimated $498K and bringing the position to 117,155 shares worth $2.82M. The position accounts for 0.25% of the portfolio, ranked #57.

Private Capital Management (Florida) first reported a position in PFE in Q3 2022 and has held it in 15 quarters since. 2,828 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Private Capital Management (Florida) held 117,155 shares of Pfizer worth $2.82M as of Q2 2026.
  • Private Capital Management (Florida) bought 19,038 Pfizer shares in Q2 2026, an estimated $498K.
  • Pfizer made up 0.25% of Private Capital Management (Florida)'s portfolio in Q2 2026, its #57 holding.
  • Private Capital Management (Florida) first reported a position in Pfizer in Q3 2022 and has held it in 15 quarters since.
  • 2,828 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Private Capital Management (Florida)'s 13F filing for Q2 2026, filed 14 Aug 2026.